Images in clinical medicine. Meckel's diverticulum in action.

published_or_final_versio

Three Extensions of Tong and Richardson’s Algorithm for Finding the Optimal Path in Schedule-Based Railway Networks

published_or_final_versio

Editorial: Advanced methods for public transport system management

published_or_final_versionSpringer Open Choice, 01 Dec 201

Advancement of the annual traffic census in Hong Kong

This paper summarises the process, findings and recommendations of a recently completed joint university consultancy project that reviewed the annual traffic census (ATC) in Hong Kong. The results of a survey that assessed the usefulness of the census report are presented, together with an overview of the existing traffic data collection process and traffic detection equipment. Areas for improvement are then identified, including the sampling strategies for the collection of vehicle classification and occupancy data, the procedure for the development of group scaling factors, the method for the selection of core and coverage stations, the approaches to developing growth factors and traffic flow estimation, the presentation method and database structure of the census framework, and the manpower requirements. Based on these identified areas, a new computer program is developed to integrate all of the tasks of the census report and to produce the results in CD-ROM format. Finally, concluding remarks are given together with recommendations for further study.published_or_final_versio

Assessing self-efficacy behaviour of type 2 diabetes mellitus in primary care

published_or_final_versio

Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B

Lamivudine monoprophylaxis against hepatitis B virus (HBV) reinfection after liver transplantation is associated with recurrence due to escape mutants and second generation recombinant HBV vaccine is not effective. We studied the efficacy of two courses each of three double-doses (20 ug) of third-generation recombinant pre-S containing vaccine (Sci-B-Vac™) in 20 patients on lamivudine prophylaxis at a median of 637 days (range, 390-2666 days) after transplantation. At enrollment, all patients were seronegative for HBsAg, anti-HBs and HBVDNA (by qPCR). Lamivudine (100 mg/day) was continued throughout the study. Five patients (25%) responded to the first course and five additional patients responded after the second course (overall response rate 50%). The response rate was 88% in patients younger than 50 years old and 25% in older patients (p = 0.02). The median peak anti-HBs titer was 153 mIU/mL with six responders having a titer >100 mIU/mL and seven sustained >6 months. Among seven previous nonresponders to second generation recombinant vaccine, three (44%) responded. At the end of the study, all patients remained seronegative for HBsAg. In conclusion, Sci-B-Vac™ is effective in about 50% of patients receiving lamividine prophylaxis and may prevent recurrence due to escape mutants. © 2006 The Authors.postprin

Media coverage of liver transplant events promotes donations from the deceased

Commentarypublished_or_final_versio

Confirmatory factor analysis on traditional Chinese version of 26-item Diabetes Self-Efficacy Scale (C-DSES) in Chinese patients with type 2 diabetes mellitus

published_or_final_versio

Lowered Immune Cell Function in Liver Recipients Recovered From Posttransplant Lymphoproliferative Disease Who Developed Graft Tolerance

published_or_final_versio